MENU
+Compare
HYPMY
Stock ticker: OTC
AS OF
Nov 13 closing price
Price
$4.78
Change
-$0.21 (-4.21%)
Capitalization
3.09B

HYPMY Hypera SA Forecast, Technical & Fundamental Analysis

Hypera SA is a specialty and generic drug manufacturing company... Show more

HYPMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for HYPMY with price predictions
Nov 12, 2025

HYPMY's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for HYPMY turned positive on October 20, 2025. Looking at past instances where HYPMY's MACD turned positive, the stock continued to rise in of 60 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 22, 2025. You may want to consider a long position or call options on HYPMY as a result. In of 115 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

HYPMY moved above its 50-day moving average on October 27, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HYPMY crossed bullishly above the 50-day moving average on October 30, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HYPMY advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .

HYPMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HYPMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.307) is normal, around the industry mean (18.827). P/E Ratio (19.475) is within average values for comparable stocks, (71.764). HYPMY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). Dividend Yield (0.043) settles around the average of (0.031) among similar stocks. P/S Ratio (2.313) is also within normal values, averaging (39.291).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HYPMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HYPMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
HYPMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

HYPMY paid dividends on January 12, 2023

Hypera SA HYPMY Stock Dividends
А dividend of $0.06 per share was paid with a record date of January 12, 2023, and an ex-dividend date of December 29, 2022. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Avenida Magalhaes de Castro, 4800
Phone
N/A
Employees
10301
Web
https://www.hypermarcas.com.br
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMALX9.87-0.07
-0.70%
American Century Small Cap Dividend G
BRUFX568.17-4.24
-0.74%
Bruce
GBLAX41.75-0.38
-0.90%
American Funds Global Balanced A
CSMFX24.59-0.45
-1.80%
Carillon Scout Mid Cap C
RPFFX10.79-0.20
-1.82%
Royce Premier Service

HYPMY and Stocks

Correlation & Price change

A.I.dvisor tells us that HYPMY and PLNH have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYPMY and PLNH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
+1.22%
PLNH - HYPMY
21%
Poorly correlated
+6.91%
CPIX - HYPMY
20%
Poorly correlated
+7.00%
GLASF - HYPMY
20%
Poorly correlated
+3.59%
KMDA - HYPMY
20%
Poorly correlated
+3.12%
JUSHF - HYPMY
18%
Poorly correlated
-10.77%
More

Groups containing HYPMY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
+1.22%
Pharmaceuticals: Generic
industry (214 stocks)
13%
Poorly correlated
-1.00%